Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.40 +0.05 (+3.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Transcode Therapeutics (RNAZ) Operating Leases (2023 - 2025)

Updated

Transcode Therapeutics (RNAZ) posted Operating Leases of $38,291 for Q4 2023, down 79.8% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Operating Leases (2023 - 2025) Analysis & Trends

Since Q1 2023, Transcode Therapeutics has reported Operating Leases for 4 quarters.

  • According to Business Quant data, Operating Leases for the three prior quarters was $189,766 (Q3 2023), $265,652 (Q2 2023) and $377,813 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Transcode Therapeutics 1.37 Mn -40.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 832,875.00
Dec 31, 2023 38,291.00
Sep 30, 2023 189,766.00
Jun 30, 2023 265,652.00
Mar 31, 2023 377,813.00
API Access

Transcode Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RNAZ&period=max&api_key=YOUR_API_KEY